Press Releases

Mr. Driscoll’s deep experience in the biopharmaceutical industry particularly the immuneoncology field makes him ideally...

Findings indicate proof of mechanism and strong antitumor efficacy in preclinical models SOUTHLAKE, Texas –...

Findings indicate favorable tolerability and proof of mechanism in various solid tumors SOUTHLAKE, Texas –...

Grant to support expanded application of lead product, ONM-100, for imaging metastatic disease that may...

Publication data suggests ONM-100 was safe and provides preliminary feasibility data for use in resection...

Two abstracts and posters highlight the diverse applications of OncoNano’s ultra pH-sensitive micelle technology SOUTHLAKE,...

- Presentation will highlight the technology of pH-sensitive micelles for tumor-agnostic intraoperative detection of residual...

Funding will support pre-clinical and clinical development through Phase 1 trial of ONM500, an immunoadjuvant...

Proceeds will be used to support new and ongoing cancer imaging clinical trials and to...

ONM-100 was able to detect occult disease which was otherwise missed by standard surgery and...